Company Overview of HealthLinx Limited
As of March 12, 2015, HealthLinx Limited was acquired by Manalto Limited, in a reverse merger transaction. HealthLinx Limited engages in the identification and development of novel, non-invasive, serum, and plasma based multi marker diagnostics. It primarily develops Ovplex, an ovarian cancer diagnostic; and IgY. The company is based in Melbourne, Australia.
50 Queen Street
Melbourne, VIC 3000
61 3 8692 9000
Key Executives for HealthLinx Limited
HealthLinx Limited does not have any Key Executives recorded.
HealthLinx Limited Key Developments
Similar Private Companies By Industry
|AbRegen Pty Ltd.||Asia|
|AdAlta Pty Ltd.||Asia|
|Advanced Wound Care Pty Ltd.||Asia|
|Agriliance Pty Ltd.||Asia|
|AION Diagnostics Limited||Asia|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact HealthLinx Limited, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.